GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » MetLife Inc (NYSE:MET) » Definitions » 3-Year Sharpe Ratio

MET (MetLife) 3-Year Sharpe Ratio : 0.18 (As of Jul. 05, 2025)


View and export this data going back to 2000. Start your Free Trial

What is MetLife 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-07-05), MetLife's 3-Year Sharpe Ratio is 0.18.


Competitive Comparison of MetLife's 3-Year Sharpe Ratio

For the Insurance - Life subindustry, MetLife's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MetLife's 3-Year Sharpe Ratio Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, MetLife's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where MetLife's 3-Year Sharpe Ratio falls into.


;
;

MetLife 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


MetLife  (NYSE:MET) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


MetLife 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of MetLife's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MetLife Business Description

Address
200 Park Avenue, New York, NY, USA, 10166-0188
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
Executives
Bill Pappas officer: EVP, Global Tech. & Ops. METLIFE, INC., 200 PARK AVENUE, NEW YORK NY 10166
Michel Khalaf director, officer: President & CEO 200 PARK AVENUE, NEW YORK NY 10166
Marlene Debel officer: EVP & Chief Risk Officer METLIFE, INC., 200 PARK AVENUE, NEW YORK NY 10166
Ramy Tadros officer: President, U.S. Business 200 PARK AVENUE, NEW YORK NY 10166
Jeh C. Johnson director 77 BEALE ST., P.O. BOX 770000, SAN FRANCISCO CA 94177
Robert Glenn Hubbard director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Susan M Podlogar officer: EVP & Chief HR Officer 200 PARK AVENUE, NEW YORK NY 10166
Steven J Goulart officer: EVP & Chief Investment Officer 200 PARK AVENUE, NEW YORK NY 10166
Carla A Harris director 702 SW 8TH STREET, BENTONVILLE AR 72716
Gerald L Hassell director
Diana Mckenzie director METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Carlos M Gutierrez director 5 GREENWAY PLAZA, STE 110, HOUSTON TX 77046
Denise M Morrison director METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Mark A Weinberger director METLIFE, INC., 200 PARK AVENUE, NEW YORK NY 10166
William E Kennard director METLIFE, INC., 200 PARK AVENUE, NEW YORK NY 10166